BTL-699-2 Device for Generalized Anxiety Disorder

Device for Treating Generalized Anxiety

Recruiting N/A Interventional Study
Generalized Anxiety Disorder (GAD)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
22 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
40 (estimated)
Sponsor
BTL Industries Ltd. · Industry
Who this trial is looking for

This trial is looking for adults aged 22 and older with Generalized Anxiety Disorder (GAD) to see if a special device can help reduce their anxiety. Participants will attend 8 treatment sessions over about 4 weeks and answer some questionnaires about their anxiety.

Are You a Good Fit for This Trial?
Rules you out Severe heart disordersSevere respiratory issuesSevere kidney issuesNeurological disorders

You may be able to join if

  • I am at least 22 years old.
  • I have been diagnosed with Generalized Anxiety Disorder.
  • I can have my motor threshold determined.
  • I am willing to avoid other anxiety treatments during the study.
  • I can follow study instructions and attend all visits.
  • I will use birth control if I can become pregnant.
  • I have been on my current medications for at least 4 weeks without changes.

You may not be able to join if

  • I have metallic objects in or near my head.
  • I have any implanted stimulation devices.
  • I have a tendency to seizure or a seizure disorder.
  • I am currently taking anticoagulation therapy.
  • I have severe or life-threatening conditions.
  • I am pregnant.
  • I currently have active suicidal intent.
  • I have a history of suicide attempts in the last 3 years.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if treatment with the BTL-699-2 device (non-invasive repetitive transcranial magnetic stimulation) can decrease anxiety symptoms in adults (aged 22 years and older) diagnosed with Generalized Anxiety Disorder (GAD). The main questions it aims to answer are: Does the accelerated treatment protocol using the BTL-699-2 device reduce self-reported anxiety s…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥ 22 years * A diagnosis of GAD according to DSM-5 criteria, confirmed by a qualified clinician at screening * Ability to determine the motor threshold of the participant. The participant's motor threshold could be established as the minimum stimulus required to induce con…
Contacts

No contact information available.